Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Combination of viral and bacterial antigens
Reexamination Certificate
2007-12-18
2007-12-18
Campell, Bruce R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Combination of viral and bacterial antigens
C424S202100, C424S203100, C424S221100, C424S247100, C424S241100, C424S215100, C424S283100, C435S236000, C435S237000
Reexamination Certificate
active
11194159
ABSTRACT:
Inactivated scours vaccines for immunization and protection of bovine animals from disease caused by infection with bovine rotavirus and bovine coronavirus, which comprise and effective amount of at least one inactivated viral strain are described. Polyvalent inactivated vaccines further comprising an effective amount of an antigenic component which is protective against one or more additional pathogenic organisms or viruses are also disclosed. Said vaccines are prepared from one or more strains of rota- and coronavirus,C. perfringensType C bacteria andE. colibacteria, and combinations thereof. Preferably, a polyvalent inactivated vaccine is provided for parenteral administration. Passive immunity is achieved in neonatal calves via immunization of pregnant cows prior to birth.
REFERENCES:
patent: 4298597 (1981-11-01), Acres et al.
patent: 4636385 (1987-01-01), Plotkin et al.
patent: 5916570 (1999-06-01), Kapil
patent: 6083512 (2000-07-01), Roberts
patent: 6974577 (2005-12-01), Knape et al.
Castro, Anthony E., Veterinary Diagnostic Virology, pp. 92-96, Mobsy Year Book (1992).
Harper, David R., Virology, p. 24, BIOS Scientific Publishers Limited (1993).
House, J.A., “Economic Impact of Rotavirus and Other Neonatal Disease Agents in Animals”, JAVMA, vol. 173, pp. 573-576 (1978).
Milane et al., “Characterization of Monoclonal Antibodies to the Hermagglutinin-Esterase Glycoprotein of a Bovine Coronavirus Associated with Winter Dysentery and Cross-reactivity to Field Isolates”, Journal of Clinical Microbiology, vol. 35, pp. 33-40, (1997).
Castro, Anthony E., Veterinary Diagnostic Virology, pp. 126-130, Mobsy Year Book (1992).
K. Fukai, “Prevalence of Calf Diarrhea Caused by Bovine Group A Rotavirus Carrying G Serotype 8 Specificity”, Veterinary Microbiology, vol. 66, pp. 301-311, (1993).
Harper, David R., Virology, p. 322, BIOS Scientific Publishers Limited (1993).
W. Lu, “Characterization of the Bovine Group A Rotavirus Strain Neonatal Calf Diarrhea Virus-Cody (NCDV-cody)”, Journal of Clinical Microbiology, vol. 33, pp. 990-994, (1995).
Dykstra Stephanie
Knape Kelly
Tinant Mary
Boesen Agnieszka
Campell Bruce R.
Novartis AG
Womble Carlyle Sandridge & Rice PLLC
LandOfFree
Inactivated bovine scours vaccines, process and method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactivated bovine scours vaccines, process and method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivated bovine scours vaccines, process and method of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3880857